CNS Pharmaceuticals Inc (CNSP)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CNSP market cap is 7.76M. The company's latest EPS is USD -0.3279 and P/E is -0.34.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.53M | -5.38M | -3.55M | -2.53M | -5.63M |
| Net Income | -4.52M | -5.38M | -3.55M | -2.53M | -5.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.83M | -9.46M | -14.03M | -15.27M | -18.87M |
| Net Income | -3.88M | -9.46M | -14.04M | -15.27M | -18.85M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.33M | 1.7M | 1.66M | 2.47M | 7.41M |
| Total Liabilities | 4.07M | 6.13M | 6.09M | 6.76M | 4.06M |
| Total Equity | -1.74M | -4.43M | -4.43M | -4.29M | 3.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.91M | 15.85M | 8.76M | 13.05M | 1.7M |
| Total Liabilities | 311k | 1.91M | 2.14M | 4.92M | 6.13M |
| Total Equity | 7.6M | 13.95M | 6.62M | 8.13M | -4.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.6M | -14.14M | -3.19M | -4.84M | -11.64M |
| Investing | -2k | -4k | N/A | N/A | N/A |
| Financing | 2.46M | 4.64M | 3.46M | 5.79M | 18.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.55M | -7.32M | -13.54M | -10.56M | -14.14M |
| Investing | -20k | -18k | -6k | -4k | -4k |
| Financing | 10.26M | 14.13M | 4.51M | 15.61M | 4.64M |
| Market Cap | 7.76M |
| Price to Earnings Ratio | -0.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.46 |
| Price to Book Ratio | -1.43 |
| Dividend Yield | - |
| Shares Outstanding | 57.49M |
| Average Volume (1 week) | 20.83M |
| Average Volume (1 Month) | 13.13M |
| 52 Week Change | -99.05% |
| 52 Week High | 23.90 |
| 52 Week Low | 0.0835 |
| Spread (Intraday) | 0 (0.74%) |
| Company Name | CNS Pharmaceuticals Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.cnspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
